Larvol Delta - A-Phase-I-Trial-to-Evaluate-the-Safety-and-Tolerability-Profile-of-HPV-Vaccine

nonavalent HPV vaccine - Beijing Health Guard Biotech, R-Pharm

http://clinicaltrials.gov/ct2/show/NCT05680454

Jan 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev